Xenon Pharmaceuticals Inc (XENE)
EBITDA Margin
0.00%
Quarterly · Period ending:
XENE EBITDA Margin
Latest reported0.00%period ending
Latest reported0.00%period ending
XENE Quarterly EBITDA Margin (-46.90% → 0.00%)
Quarterly ebitda margin
High-resolution chart · PNG
XENE ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -961.0533% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -28,613.6364% | |
| -5,585.8209% | |
| -193.8512% | |
| -657.4257% | |
| -189.4264% | |
| -1,003.9225% | |
| -363.9972% | |
| -247.0097% | |
| -135.5966% | |
| 0.7995% | |
| -99.6185% | |
| -327.9664% | |
| -239.9714% | |
| 0% | |
| 0% | |
| -134.3333% | |
| 0% | |
| 0% | |
| 0% | |
| -49,400% | |
| -2,868.9394% | |
| -51,493.3333% | |
| -48,887.5% | |
| -1,408.5106% | |
| -1,734.6247% | |
| -1,481.1138% | |
| -894.5092% | |
| -71.8624% | |
| -12.9949% | |
| 11.9624% | |
| -147.8803% | |
| 4.92% | |
| 67.0355% | |
| 29.3129% | |
| 24.1352% | |
| 39.28% | |
| 61.9021% | |
| 14.0737% | |
| 14.0737% | |
| -46.9006% | |
| -46.9006% |